Technological innovation: a new course for the future development of aortic surgery
时间: 2024-05-31
作者: 小编:
阅读量: 294
关键词:


Prof. Junming Zhu, Deputy Editor-in-Chief of the Journal and Professor of Beijing Anzhen Hospital of Capital Medical University, gave a lecture on “Scientific and Technological Innovation: New Direction for Future Development of Aortic Surgery” at the “2024 Zijinshan Cardiovascular Forum”, and the article was published in Issue No. 3 of the Journal in 2024.

Ancient Roman physician Galen defined the anatomical concept of aneurysm as early as the 2nd century A.D., but aortic surgery was once considered a “surgical no-go area”. It was not until the mid-20th century that aortic surgery finally saw its golden age. Under the leadership of Professors Debakey and Cooley, surgical treatment of all types of aortic disease became possible. Over the next half century, the results of open surgery have improved dramatically, thanks to technological innovations and translational applications in various fields of technology. With the rise of minimally invasive, endovascular repair, and hybrid surgical techniques, coupled with reliable and convenient diagnostic imaging, effective perioperative organ preservation, and critical care strategies, the aortic surgical team has been able to provide a safe and reliable short- and long-term prognosis for the vast majority of patients. In this article, we will focus on the recent scientific and technological innovations and translational achievements in the field of aortic surgery, as well as the future trends of the discipline.



01

Risk prediction of adverse events in aortic disease

Ascending aortic aneurysm (AAA) is strongly associated with aorticadverse events (AAEs) such as aortic rupture, coarctation, and death.The 2022 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines for the Diagnosis and Treatment of Aortic Disease state that The 2022 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines for the Diagnosis and Treatment of Aortic Disease state that AAA prophylactic intervention is indicated for diameters ≥5.5 cm, or 5.0 cm in combination with connective tissue disease, rapid diameter growth, or other risk factors; however, most AAEs occur at diameters <5.5 cm, which has been viewed as the “aortic paradox” [1-3]. The Yale team concluded that the indication for AAA preventive intervention should be “shifted left” to 5 cm [4]. However, the controversy is that the risk of surgical death is higher at this indication than the annual risk of AAEs (2.0% vs. 1.4%).

In recent years, superior predictors of efficacy over diameter have been developed, including the aortic dimensional index, diameter-height index, aortic height index, and ascending aortic length [5-9].Wu et al [10] concluded that ascending aortic morphology can vary considerably, even when aortic diameter and length values are similar. In contrast, aortic volume, as a three-dimensional property index, has the dual advantage of simultaneously evaluating the hemodynamic status of AAA (transverse) and the mechanical stress on the aortic wall (longitudinal), which helps to accurately predict the risk of AAEs. With the increasing research in fluid dynamics and biomechanics, the wall stress rupture potential index, numerical prediction of wall stress, severity parameter, and finite element analysis rupture index have begun to be used for risk prediction of ruptured abdominal aortic aneurysms [9,11-14]. However, considering the complexity of the proximal structure of the ascending aorta, the relevant indices still need to be validated in AAA.


02

Technical evolution and changes in aortic arch surgery

Frozen elephant trunk stent technique (FET) has been gradually and widely used in the surgical treatment of type A aortic dissection (TAAD), which can effectively seal the primary breach, expand the true lumen, and promote the remodeling of the false lumen. The 9-year follow-up of 518 cases of acute TAAD in Beijing Anzhen Hospital showed that the false lumen closure rate of the descending aorta by Sun's procedure reached more than 95% [15,16]. Although the FET technique greatly simplifies the complexity of surgical operation, even in large cardiac centers with mature experience, the FET technique still inevitably involves systemic hypothermia and circulatory arrest during distal open anastomosis. There are three core variables for organ protection during intraoperative maneuvers: optimal core temperature, time to circulatory arrest, and cerebral perfusion at the time of circulatory arrest [17].

The more commonly used perfusion modalities in clinical practice include: deep hypothermia to stop circulation, deep hypothermia to stop circulation combined with retrograde cerebral perfusion, and moderate hypothermia to stop circulation accompanied by cisplaced cerebral perfusion [18]. Among them, moderate hypothermia combined with unilateral cisplaced cerebral perfusion is considered to be the safest strategy for circulatory management [19]. Large randomized controlled studies are still needed in the future to provide high-quality looking medical evidence to prove the optimal intraoperative core temperature and perfusion strategies. In addition, domestic and international researchers have favored changing the FET design or combining different perfusion modalities to break through the bottleneck of the current technology, using intra-balloon block [20-22], extra-stent vessel block [23], triple-branched stent vessels [24], and a new sutureless integrated stent vessel [25] to increase the core temperature and shorten distal anastomotic stoppage of the circulatory time, or simplifying distal anastomosis by using cutting anastomoses [26]. The above innovative technologies and novel vessels still need to be objectively evaluated using the GRADE EtD framework as a criterion to prove the practical value through extensive clinical studies. In addition, well-constructed open implantable vessels should have the advantages of easy release without increasing technical complexity; good flexibility, conforming to the aortic curvature and having a tapered distal end; a biocompatible surface with minimal blood permeability; and a distal anastomosis that facilitates secondary interventions [27].


03

Expanded application of endoluminal repair techniques in aortic surgery

The endoluminal repair technique is an alternative for high-risk patients when surgical treatment is not available. Previous studies concluded that endoluminal repair was previously thought to be unable to be applied in this segment of the aorta due to the structural complexity of the aortic root and ascending aorta.In 2014, Rylski et al[28] proposed an interventional device for aortic valve combined with ascending aortic replacement to break this technical bottleneck, but anatomical feasibility of this technique in the past was usually below 40%. In China, Prof. Guo Wei's team changed the design concept of the previous aortic root mesh structure and innovatively proposed a modular Endo-Bentall stent system with a fully coated structure, including a stent with two internal branches, two coronary reconstruction stents, and an interventional aortic valve with a connecting segment stent [29]. The operation was performed to reconstruct the ascending aorta, coronary arteries, aortic root and valve sequentially from distal to proximal. The anatomical applicability is increased to 66.4% and is more suitable for TAAD patients with intimal tears in the aortic root. The system is designed to allow for the internal branches required for coronary reconstruction, ensuring adequate myocardial perfusion during the operation. The modular combination avoids the drawbacks of customized stents and solves the problem of individualization. In the future, it is hoped that prospective cohort studies or randomized controlled studies will demonstrate the efficacy and safety of this stent system. Nowadays, the practical clinical application of the Endo-Bentall concept is still less reported, but the short-term therapeutic effect is more favorable [30-32]. Theoretically, Endo-Bentall will benefit more patients with TAAD. On the other hand, the use of Endo-Bentall has been reported to be not rigorous, and some of the cases were actually Endo-Wheat surgery, which should be strictly subclassified and the use of related academic terms should be standardized in the future.

In the 2022 ACC/AHA Guidelines for the Diagnosis and Treatment of Aortic Disease, open surgical repair of thoracoabdominal aortic aneurysm (TAAA) is a Class I recommendation, and endoluminal stent repair is only a Class IIb recommendation [33]. However, a German study found that the volume of endoluminal treatment for TAAA increased by 70% in ten years and the in-hospital mortality rate was much lower than that of open surgery (10.6% versus 23.9%) [34]. Beginning in the 1990s, clinical specialists used reinforced open or directional branching stents. Currently, the technique has evolved from the use of physician-modified endoluminal stents to individualized finished endoluminal stents. One study showed that open branch endoluminal repair reduced early overall mortality to 6.5% [35]. Despite technological advances, the intercostal arteries may have the disadvantage of not being able to be reconstructed by endoluminal treatment due to technical and anatomical limitations, which has raised concerns that extensive aortic coverage may increase the risk of spinal cord injury (SCI). The incidence of SCI has been reported to be 9.6% after open repair of TAAA [36] and 8% with endoluminal treatment [37]. Conventional monitoring and protection strategies such as motor evoked potentials, somatosensory evoked potentials, and cerebrospinal fluid drainage could not significantly improve the incidence of SCI [38]. Currently, in this regard, Etza et al [39] found that the intercostal segmental vessels are not the only arteries supplying the spinal cord, and their surrounding vascular plexus forms a dynamic blood supply mechanism. When the segmental arterial blood supply is insufficient, the collateral blood supply increases, which explains to some extent the failure of segmental vascular perfusion alone to reduce the incidence of SCI. Therefore, the concept of “minimally invasive staged segmental arterial coil embolization (MIS2ACE)” has been proposed for the initiation of the paraspinal collateral branch network prior to open or endoluminal TAAA repair to prevent postoperative SCI [40]. Animal experiments demonstrated good prognostic results [41], which is currently being studied in a multicenter randomized controlled trial (RCT) study with a total of 9 countries and 17 cities participating in the study [42], which, combined with noninvasive real-time monitoring of paraspinous muscle oxygenation by near-infrared spectroscopy, holds the promise of advancing the birth of new spinal cord protection strategies in the future.


04

Multidisciplinary cross-fertilization of research in aortic surgery

With the rapid development of basic medicine, information engineering, artificial intelligence and other theories and technologies, the technical advantages of different disciplines can be used to analyze the data in multiple dimensions and elaborate the idea of causality of aortic diseases, which provides a new perspective for a more complete explanation of aortic diseases, a more comprehensive diagnosis to predict the diseases, and a multidimensional treatment of aortic diseases. Related scholars have constructed nanocomplexes based on demonstrable pathogenesis of aortic coarctation through suitable and stable carriers, which can achieve targeted therapy of aortic coarctation.Xu et al[43] used a multifunctional delivery nanosystem consisting of gadolinium-chelated tannins, low-toxicity cationic ethanolamine amine polymethylmethacrylamide glycidyl ester, and collagen-targeting peptides of type IV collagen by synthesizing a multifunctional delivery nanosystem for targeting nucleic acids for aortic coarctation.The results of this study are summarized in the following table, early diagnosis and noninvasive monitoring; Cheng et al [44] developed a nanotherapeutic for abdominal aortic aneurysms using reactive oxygen-responsive nanoparticles and rapamycin in combination with integrin peptide ligands and macrophage membrane mimetic stealth. Given the rarity of aortic disease compared to other cardiovascular diseases, over the past 5 years, researchers investigating the genetic mechanisms of aortic disease have used new gene sequencing technologies to analyze large datasets and accelerate the identification of genetic associations with aortic phenotypes.Klarin et al[45] used GWAS and PheWas to establish correlations between causative genes and high-risk phenotypes; with the help of Mendelian randomization Klarin et al[45] used GWAS and PheWas to establish the correlation between causative genes and high-risk phenotypes; Mendelian randomization analysis to clarify the causal relationship between causative genes and risk factors for the onset of the disease; and scRNA-seq and snRNA-seq to identify nine risk genes affecting the expression of aortic genes and the eight cell types in which they preferentially acted; they ultimately established a genetically based genetic risk score for TAAD, and validated the results with six large external cohorts.

All in all, the comprehensive diagnosis and treatment of aortic surgery has taken a qualitative leap, fueled by the revolutionary achievements of scientific and technological innovations. However, there are still a number of urgent scientific research problems in aortic diseases: how to establish a preclinical model that better meets the characteristics of the disease and reduces the actual differences with the human body; how to explore the correlation between the genetic information and the disease phenotype based on the deep learning of big data or artificial intelligence, so as to improve the accuracy of the disease prediction; how to discover new targets for interventions and research and development of new medicines on the basis of this; how to establish large-scale prospective or randomized controlled studies on the existing surgical techniques or perioperative management strategies; and how to establish a quantifiable and standardized diagnostic and treatment system. Carry out large-scale prospective or randomized controlled studies to establish a quantifiable and standardized diagnosis and treatment system, and provide high-quality evidence-based medical evidence. In the author's opinion, the future development of the discipline should be centered on aortic disease, establish a broad aortic surgery team with multidisciplinary collaboration, cultivate new composite talents with scientific and technological innovation thinking, and explore precise “whole life cycle” sequential prevention and treatment strategies, in order to further improve the quality of medical care in aortic surgery and the quality of short- and long-term prognosis of patients. We will further improve the medical quality of aortic surgery and further improve the short and long term prognosis of patients.


Format for citing this article

ZHU Jun-Ming, CHEN Su-Wei, DONG Wen-Tao. Technological innovation: a new direction for the future development of aortic surgery[J]. China Cardiovascular Disease Research, 2024, 22(3):213-218.

DOI:10.3969/j.issn.1672-5301.2024.03.005


References omitted